STAT+: Pharmalittle: Genentech weighs delaying cancer therapy after drug pricing law; Novo continues to restrict supplies of low-dose Wegovy

August 10, 2023 San Francisco Biotechnology Network News News, Syndication, Uncategorized Comments Off on STAT+: Pharmalittle: Genentech weighs delaying cancer therapy after drug pricing law; Novo continues to restrict supplies of low-dose Wegovy

CEO says Medicare negotiation could encourage Genentech to slow-walk ovarian cancer drug for smaller population.
Click here to view original post